10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q3 2012

Filing Information

Form Type	10-Q
Accession Number	`0001144204-12-062366`
Period End Date	20120930
Filing Date	20121114
Fiscal Year	2012
Fiscal Period	Q3
XBRL Instance	bpth-20120930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 62 Cash Flow Statement 74

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$332.86K	USD	Point-in-time
Cash	`Cash`	-	USD	Point-in-time
Cash	`Cash`	$952.25K	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$238.56K	USD	Point-in-time
Cash	`Cash`	$983.29K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$153.00K	USD	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$79.50K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$48.44K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$45.40K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.15M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$457.76K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	58.92M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	58.33M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	58.92M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	58.33M	shares	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$2.87M	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$-888.08K	USD	Point-in-time
Additional paid in capital for shares to be issued, shares of common stock	`CommonStockIssuableSharesIssuable`	3.15M	shares	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$-791.46K	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$2.08M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.61M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.07M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.23M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$65.42K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$121.54K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	$8.58K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	$67.97K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$46.08K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$105.57K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$41.00K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$39.00K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$50.00K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$39.54K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$316.13K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$268.57K	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$316.13K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$268.57K	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 58,918,713 and 58,325,169 shares issued and outstanding as of 9/30/12 and 12/31/11, respectively	`CommonStockValue`	$58.92K	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 58,918,713 and 58,325,169 shares issued and outstanding as of 9/30/12 and 12/31/11, respectively	`CommonStockValue`	$58.33K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$12.41M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$12.50M	USD	Point-in-time
Additional paid in capital for shares to be issued	`OtherAdditionalCapital`	$945.00K	USD	Point-in-time
Additional paid in capital for shares to be issued	`OtherAdditionalCapital`	-	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$9.55M	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$11.70M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$1.80M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$2.91M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$2.07M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.23M	USD	Point-in-time

Income Statement 62 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	3 Qtrs
Amortization	`AdjustmentForAmortization`	$936.58K	USD	22 Qtrs
Revenue	`Revenues`	-	USD	22 Qtrs
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	3 Qtrs
Amortization	`AdjustmentForAmortization`	$157.49K	USD	3 Qtrs
Amortization	`AdjustmentForAmortization`	$145.12K	USD	3 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$6.80M	USD	22 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$729.57K	USD	3 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$246.09K	USD	1 Quarter
General & administrative	`GeneralAndAdministrativeExpense`	$327.38K	USD	1 Quarter
General & administrative	`GeneralAndAdministrativeExpense`	$1.00M	USD	3 Qtrs
Total operating expense	`OperatingExpenses`	$2.15M	USD	3 Qtrs
Technology impairment charge	`OtherAssetImpairmentCharges`	$345.00K	USD	3 Qtrs
Technology impairment charge	`OtherAssetImpairmentCharges`	-	USD	3 Qtrs
Total operating expense	`OperatingExpenses`	$504.49K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$1.56M	USD	3 Qtrs
Total operating expense	`OperatingExpenses`	$840.49K	USD	1 Quarter
Technology impairment charge	`OtherAssetImpairmentCharges`	$345.00K	USD	Annual
Total operating expense	`OperatingExpenses`	$12.02M	USD	22 Qtrs
Technology impairment charge	`OtherAssetImpairmentCharges`	$690.00K	USD	22 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-840.49K	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-504.49K	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-2.15M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-12.02M	USD	22 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-1.56M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$77.08K	USD	22 Qtrs
Interest income	`InvestmentIncomeInterest`	$768.00	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.17K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$870.00	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$26.00	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	-	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	-	USD	3 Qtrs
Other income	`OtherNonoperatingIncome`	-	USD	3 Qtrs
Other income	`OtherNonoperatingIncome`	$244.48K	USD	22 Qtrs
Other income	`OtherNonoperatingIncome`	-	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$89.00	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$487.00	USD	3 Qtrs
Other expense	`OtherNonoperatingExpense`	$4.02K	USD	22 Qtrs
Other expense	`OtherNonoperatingExpense`	$200.00	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$471.00	USD	3 Qtrs
Total Other Income	`NonoperatingIncomeExpense`	$281.00	USD	3 Qtrs
Total Other Income	`NonoperatingIncomeExpense`	$670.00	USD	1 Quarter
Total Other Income	`NonoperatingIncomeExpense`	$-63.00	USD	1 Quarter
Total Other Income	`NonoperatingIncomeExpense`	$317.54K	USD	22 Qtrs
Total Other Income	`NonoperatingIncomeExpense`	$1.70K	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-2.15M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-503.82K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-840.55K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.56M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-11.70M	USD	22 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.26	USD	22 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	3 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	3 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	58.90M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	58.72M	shares	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	52.40M	shares	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	56.15M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	45.35M	shares	22 Qtrs

Cash Flow Statement 74 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.15M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-503.82K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-840.55K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.56M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-11.70M	USD	22 Qtrs
Amortization	`AdjustmentForAmortization`	$936.58K	USD	22 Qtrs
Amortization	`AdjustmentForAmortization`	$157.49K	USD	3 Qtrs
Amortization	`AdjustmentForAmortization`	$145.12K	USD	3 Qtrs
Technology impairment	`OtherAssetImpairmentCharges`	$345.00K	USD	3 Qtrs
Technology impairment	`OtherAssetImpairmentCharges`	-	USD	3 Qtrs
Technology impairment	`OtherAssetImpairmentCharges`	$345.00K	USD	Annual
Technology impairment	`OtherAssetImpairmentCharges`	$690.00K	USD	22 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$18.50K	USD	3 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	3 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$795.00K	USD	1 Quarter
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$318.50K	USD	22 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$45.48K	USD	3 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$363.56K	USD	3 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$3.00M	USD	22 Qtrs
Grants receivable	`IncreaseDecreaseInReceivables`	$-244.48K	USD	3 Qtrs
Grants receivable	`IncreaseDecreaseInReceivables`	-	USD	22 Qtrs
Grants receivable	`IncreaseDecreaseInReceivables`	-	USD	3 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$79.50K	USD	22 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$-73.50K	USD	3 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$-88.40K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-3.04K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-20.97K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$45.40K	USD	22 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-41.76K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-47.56K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$268.57K	USD	22 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.61M	USD	22 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.57M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-726.16K	USD	3 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$25.00K	USD	3 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$884.71K	USD	22 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$62.55K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-25.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-62.55K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-884.71K	USD	22 Qtrs
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	$435.00K	USD	22 Qtrs
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	-	USD	3 Qtrs
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	-	USD	3 Qtrs
Cash repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$15.00K	USD	22 Qtrs
Cash repayment of convertible notes	`RepaymentsOfConvertibleDebt`	-	USD	3 Qtrs
Cash repayment of convertible notes	`RepaymentsOfConvertibleDebt`	-	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$7.41M	USD	22 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.53M	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$973.15K	USD	3 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$973.15K	USD	3 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.53M	USD	3 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$7.83M	USD	22 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$744.72K	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$332.86K	USD	22 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$-619.39K	USD	3 Qtrs
Cash, beginning of period	`Cash`	$332.86K	USD	Point-in-time
Cash, beginning of period	`Cash`	-	USD	Point-in-time
Cash, beginning of period	`Cash`	$952.25K	USD	Point-in-time
Cash, beginning of period	`Cash`	$238.56K	USD	Point-in-time
Cash, beginning of period	`Cash`	$983.29K	USD	Point-in-time
Cash, end of period	`Cash`	$332.86K	USD	Point-in-time
Cash, end of period	`Cash`	-	USD	Point-in-time
Cash, end of period	`Cash`	$952.25K	USD	Point-in-time
Cash, end of period	`Cash`	$238.56K	USD	Point-in-time
Cash, end of period	`Cash`	$983.29K	USD	Point-in-time
Interest	`InterestPaid`	-	USD	3 Qtrs
Interest	`InterestPaid`	-	USD	3 Qtrs
Interest	`InterestPaid`	$445.00	USD	22 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	22 Qtrs
Common stock issued upon conversion of convertible notes	`ConversionOfStockAmountConverted1`	$420.00K	USD	22 Qtrs
Common stock issued upon conversion of convertible notes	`ConversionOfStockAmountConverted1`	-	USD	3 Qtrs
Common stock issued upon conversion of convertible notes	`ConversionOfStockAmountConverted1`	-	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.